Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTUITIVE SURGICAL INCISRG · Entity 2878 | Director | April 23, 2019 | April 25, 2019 |
| MANNKIND CORPMNKD · Entity 4792 | Director | May 20, 2026 | May 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTUITIVE SURGICAL INC
Report date April 23, 2019 · Filed April 25, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,751 |
Ending reported balance
After 2019-04-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-04-23 · Exercise / conversion · Acquired 996 · Balance 5,747 F1: This transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 6, 2019. Row 2 · 2019-04-23 · Sale · Disposed 996 · Balance 4,751 F1: This transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 6, 2019. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $462.71 · Expires 2028-04-19 | Direct | 0 |
Reported balance
After 2019-04-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-04-23 · Exercise / conversion · Disposed 996 · Balance 0 F1: This transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 6, 2019. F2: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 6, 2019.
F2: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.
MANNKIND CORP
Report date May 20, 2026 · Filed May 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 82,781 |
Reported balance
After 2026-05-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 82,781 · Balance 82,781 F1: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2: Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
F2: Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CELGENE CORP /DE/
Report date November 20, 2019 · Filed November 22, 2019
Section 16 reporting ended · disclosed 2019-11-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectFamily Trust | 0 |
Reported balance
After 2019-11-20 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2019-11-20 · Disposition to issuer · Disposed 19,847 · Balance 0 F1: Reflects disposition in connection with the Agreement and Plan of Merger (the "Merger Agreement") dated January 2, 2019, by and among Celgene Corporation ("Celgene"), Bristol-Myers Squibb Company ("BMS"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS ("Merger Sub"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the "Effective Time"), each share of Celgene common stock was converted into the right to receive (i) $50.00 in cash, (ii) one share of BMS common stock, and (iii) one contingent value right ("CVR") issued by BMS subject to and in accordance with the CVR agreement, dated November 20, 2019, by and between BMS and the Equiniti Trust Company. F2: The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.06 · Expires 2023-06-12 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-11-20 · Disposition to issuer · Disposed 3,600 · Balance 0 F4: Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement. F3: This option was fully exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $88.50 · Expires 2024-07-01 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-11-20 · Disposition to issuer · Disposed 20,700 · Balance 0 F4: Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement. F3: This option was fully exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $112.16 · Expires 2025-06-17 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-11-20 · Disposition to issuer · Disposed 10,000 · Balance 0 F4: Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement. F3: This option was fully exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $99.98 · Expires 2026-06-15 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-11-20 · Disposition to issuer · Disposed 11,000 · Balance 0 F4: Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement. F3: This option was fully exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $121.04 · Expires 2027-06-14 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-11-20 · Disposition to issuer · Disposed 10,500 · Balance 0 F4: Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement. F3: This option was fully exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.38 · Expires 2028-06-13 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-11-20 · Disposition to issuer · Disposed 13,266 · Balance 0 F4: Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement. F3: This option was fully exercisable. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-11-20 · Disposition to issuer · Disposed 300 · Balance 0 F5: Each restricted stock unit represents a contingent right to receive one share of Celgene common stock. F6: Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-11-20 · Disposition to issuer · Disposed 970 · Balance 0 F5: Each restricted stock unit represents a contingent right to receive one share of Celgene common stock. F6: Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2019-11-20 · Disposition to issuer · Disposed 4,756 · Balance 0 F5: Each restricted stock unit represents a contingent right to receive one share of Celgene common stock. F6: Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the Agreement and Plan of Merger (the "Merger Agreement") dated January 2, 2019, by and among Celgene Corporation ("Celgene"), Bristol-Myers Squibb Company ("BMS"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS ("Merger Sub"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the "Effective Time"), each share of Celgene common stock was converted into the right to receive (i) $50.00 in cash, (ii) one share of BMS common stock, and (iii) one contingent value right ("CVR") issued by BMS subject to and in accordance with the CVR agreement, dated November 20, 2019, by and between BMS and the Equiniti Trust Company.
F2: The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3: This option was fully exercisable.
F4: Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement.
F5: Each restricted stock unit represents a contingent right to receive one share of Celgene common stock.
F6: Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 20, 2018 Filed Apr 20, 2018 23:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,200 | $0.00 Strike: $185.73 | $0.00 |
DisclosureSEC source: 0001035267-18-000059 · edgardoc.xml · derivative · entry 6 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525 Underlying: Common Stock · 1,200 shares Expires 2025-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 1/3rd one year after the date of grant and 1/36th each month thereafter. Read SEC document |
| April 20, 2018 Filed Apr 20, 2018 23:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 1,200 | $458.14 | $549,765.12 |
DisclosureSEC source: 0001035267-18-000059 · edgardoc.xml · nonDerivative · entry 5 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,444 F2 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporting person on February 23, 2018. Read SEC document |
| April 20, 2018 Filed Apr 20, 2018 23:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 1,200 | $185.73 | $222,879.96 |
DisclosureSEC source: 0001035267-18-000059 · edgardoc.xml · nonDerivative · entry 4 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2018 Filed Apr 20, 2018 23:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 981 | $458.14 | $449,432.99 |
DisclosureSEC source: 0001035267-18-000059 · edgardoc.xml · nonDerivative · entry 3 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,444 F2 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporting person on February 23, 2018. Read SEC document |
| April 20, 2018 Filed Apr 20, 2018 23:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 981 | $213.97 | $209,904.57 |
DisclosureSEC source: 0001035267-18-000059 · edgardoc.xml · nonDerivative · entry 2 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 19, 2018 Filed Apr 20, 2018 23:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 332 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-18-000059 · edgardoc.xml · derivative · entry 10 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332 Underlying: Common Stock · 332 shares Expires 2022-04-19 F7 · derivative.exercise_date: Restricted Stock Units (RSUs) are granted pursuant to the 2010 Incentive Award Plan. The RSUs fully vest on the first anniversary of the date of grant. Read SEC document |
| April 19, 2018 Filed Apr 20, 2018 23:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 513 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-18-000059 · edgardoc.xml · derivative · entry 9 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 513 shares Expires 2018-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company. Read SEC document |
| April 19, 2018 Filed Apr 20, 2018 23:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 996 | $0.00 Strike: $462.71 | $0.00 |
DisclosureSEC source: 0001035267-18-000059 · edgardoc.xml · derivative · entry 8 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 996 Underlying: Common Stock · 996 shares Expires 2028-04-19 F5 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| April 19, 2018 Filed Apr 20, 2018 23:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 513 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-18-000059 · edgardoc.xml · nonDerivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were acquired from the vest and release of an RSU grant previously issued to the Filer. Read SEC document |
| July 25, 2017 Filed Jul 25, 2017 21:58 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $557.20 | $0.00 |
DisclosureSEC source: 0001035267-17-000103 · edgardoc.xml · derivative · entry 4 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 575 Underlying: Common Stock · 1,000 shares Expires 2025-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 1/3rd one year after the date of grant and 1/36th each month thereafter. Read SEC document |
| July 25, 2017 Filed Jul 25, 2017 21:58 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 1,000 | $945.60 | $945,603.00 |
DisclosureSEC source: 0001035267-17-000103 · edgardoc.xml · nonDerivative · entry 3 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 977 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 Trading Plan, entered into on June 12, 2017. Read SEC document |
| July 25, 2017 Filed Jul 25, 2017 21:58 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 1,000 | $557.20 | $557,200.00 |
DisclosureSEC source: 0001035267-17-000103 · edgardoc.xml · nonDerivative · entry 2 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 21:58 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 325 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-17-000103 · edgardoc.xml · derivative · entry 5 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325 Underlying: Common Stock · 325 shares Expires 2019-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/3 of the grant will vest on the anniversary date of the grant over a three year period, provided however that vesting will cease on termination of the Director's service to the company. Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 21:58 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 325 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-17-000103 · edgardoc.xml · nonDerivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 19:31 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionRestricted Stock Unit · Derivative | 734 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-043764 · doc4.xml · derivative · entry 3 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 734 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F4 · price: The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated on April 15, 2015)). F1 · derivative.exercise_date: One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock. F1 · derivative.expiration_date: One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 19:31 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock | 734 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-043764 · doc4.xml · nonDerivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 16:04 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock · Derivative | 5,000 | $0.00 Strike: $59.06 | $0.00 |
DisclosureSEC source: 0001209191-17-041631 · doc4.xml · derivative · entry 7 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,600 Underlying: Common Stock · 5,000 shares Expires 2023-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015)). F3 · derivative.exercise_date: The option was fully exercisable. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 16:04 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | SaleCommon Stock | 5,000 | $135.00 | $675,000.00 |
DisclosureSEC source: 0001209191-17-041631 · doc4.xml · nonDerivative · entry 4 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 16:04 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock | 5,000 | $59.06 | $295,300.00 |
DisclosureSEC source: 0001209191-17-041631 · doc4.xml · nonDerivative · entry 3 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 16:04 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock · Derivative | 5,000 | $0.00 Strike: $59.06 | $0.00 |
DisclosureSEC source: 0001209191-17-041631 · doc4.xml · derivative · entry 6 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,600 Underlying: Common Stock · 5,000 shares Expires 2023-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015)). F3 · derivative.exercise_date: The option was fully exercisable. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 16:04 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | SaleCommon Stock | 5,000 | $130.00 | $650,000.00 |
DisclosureSEC source: 0001209191-17-041631 · doc4.xml · nonDerivative · entry 2 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 16:04 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock | 5,000 | $59.06 | $295,300.00 |
DisclosureSEC source: 0001209191-17-041631 · doc4.xml · nonDerivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2017 Filed Jun 20, 2017 16:07 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock · Derivative | 5,000 | $0.00 Strike: $59.06 | $0.00 |
DisclosureSEC source: 0001209191-17-041065 · doc4.xml · derivative · entry 6 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2023-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015)). F7 · derivative.exercise_date: The option was fully exercisable. Read SEC document |
| June 19, 2017 Filed Jun 20, 2017 16:07 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | SaleCommon Stock | 5,000 | $125.00 | $625,000.00 |
DisclosureSEC source: 0001209191-17-041065 · doc4.xml · nonDerivative · entry 3 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 19, 2017 Filed Jun 20, 2017 16:07 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock | 5,000 | $59.06 | $295,300.00 |
DisclosureSEC source: 0001209191-17-041065 · doc4.xml · nonDerivative · entry 2 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2017 Filed Jun 20, 2017 16:07 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionRestricted Stock Unit · Derivative | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041065 · doc4.xml · derivative · entry 5 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334 Underlying: Common Stock · 333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F5 · derivative.exercise_price: The balance of the restricted stock units will vest on June 17, 2018. Vested shares will be delivered to the reporting person promptly after the vesting date. F6 · price: The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated on April 15, 2015)). F1 · derivative.exercise_date: One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock. F1 · derivative.expiration_date: One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock. Read SEC document |
| June 17, 2017 Filed Jun 20, 2017 16:07 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041065 · doc4.xml · nonDerivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 16:08 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionRestricted Stock Unit · Derivative | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040453 · doc4.xml · derivative · entry 5 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F8 · derivative.exercise_price: The remainder of the restricted stock units will vest as follows: 375 shares on June 15, 2018; 375 shares on June 15, 2019. Vested shares will be delivered to the reporting person promptly after the vesting date. F7 · price: The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan. F1 · derivative.exercise_date: One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock. F1 · derivative.expiration_date: One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 16:08 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040453 · doc4.xml · nonDerivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 16:08 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | GrantRestricted Stock Unit · Derivative | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040453 · doc4.xml · derivative · entry 4 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 Underlying: Common Stock · 900 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F7 · price: The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan. F6 · derivative.exercise_date: The restricted stock units will vest in three equal annual installments commencing on June 14, 2018. Vested shares will be delivered to the reporting person promptly after the vesting date. F6 · derivative.expiration_date: The restricted stock units will vest in three equal annual installments commencing on June 14, 2018. Vested shares will be delivered to the reporting person promptly after the vesting date. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 16:08 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | GrantStock Option (right to buy) · Derivative | 10,500 | $0.00 Strike: $121.04 | $0.00 |
DisclosureSEC source: 0001209191-17-040453 · doc4.xml · derivative · entry 3 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires 2027-06-14 F4 · price: The option was issued pursuant to the Company's 2017 Stock Incentive Plan. F3 · derivative.exercise_date: Option is immediately exercisable and will vest on the earlier of June 14, 2018 or the day preceding the date of the next annual stockholder meeting. Read SEC document |
| May 18, 2017 Filed May 22, 2017 23:48 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001209191-17-034522 · doc4.xml · derivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-05-17 F1 · derivative.exercise_date: The option shall vest in 36 equal monthly installments following the date of grant. Read SEC document |
| May 18, 2017 Filed May 18, 2018 14:12 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit · Derivative | 65,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-031285 · doc4.xml · derivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,200 Underlying: Common Stock · 65,200 shares Expires 2028-05-16 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Restricted stock unit shall vest immediately, but the shares shall not be delivered until the director leaves the Board. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 21:12 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 327 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-17-000075 · edgardoc.xml · derivative · entry 4 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 327 shares Expires 2020-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 21:12 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 171 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-17-000075 · edgardoc.xml · derivative · entry 3 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171 Underlying: Common Stock · 171 shares Expires 2018-02-21 F3 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 21:12 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 515 | $0.00 Strike: $814.45 | $0.00 |
DisclosureSEC source: 0001035267-17-000075 · edgardoc.xml · derivative · entry 2 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515 Underlying: Common Stock · 515 shares Expires 2027-04-20 F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 21:12 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 327 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-17-000075 · edgardoc.xml · nonDerivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired from the vest and release of an RSU grant previously issued to the Filer. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 16:14 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionStock Option (right to buy) · Derivative | 18,600 | Not disclosed Strike: $31.80 | Not disclosed |
DisclosureSEC source: 0001209191-16-149330 · doc4.xml · derivative · entry 4 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,600 shares Expires 2022-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015). F3 · derivative.exercise_date: The option was fully exercisable. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 16:14 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | SaleCommon Stock | 18,600 | $116.10 | $2,159,460.00 |
DisclosureSEC source: 0001209191-16-149330 · doc4.xml · nonDerivative · entry 2 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The shares were sold by the reporting person pursuant to a Rule 10b5-1 plan. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 16:14 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock | 18,600 | $31.80 | $591,480.00 |
DisclosureSEC source: 0001209191-16-149330 · doc4.xml · nonDerivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 16:09 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionStock Option (right to buy) · Derivative | 6,116 | Not disclosed Strike: $29.00 | Not disclosed |
DisclosureSEC source: 0001209191-16-144880 · doc4.xml · derivative · entry 6 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,116 shares Expires 2021-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015). F3 · derivative.exercise_date: The option was fully exercisable. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 16:09 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $26.96 | Not disclosed |
DisclosureSEC source: 0001209191-16-144880 · doc4.xml · derivative · entry 5 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2021-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015). F3 · derivative.exercise_date: The option was fully exercisable. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 16:09 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | SaleCommon Stock | 56,116 | $103.66 | $5,816,984.56 |
DisclosureSEC source: 0001209191-16-144880 · doc4.xml · nonDerivative · entry 3 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold by the reporting person pursuant to a Rule 10b5-1 plan in multiple transactions at prices ranging from $103.02 to 104.21, inclusive. The reporting person undertakes to provide Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 16:09 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock | 6,116 | $29.00 | $177,364.00 |
DisclosureSEC source: 0001209191-16-144880 · doc4.xml · nonDerivative · entry 2 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 16:09 UTC | CELGENE CORP /DE/ CELG · Entity 15781 | Exercise / conversionCommon Stock | 50,000 | $29.96 | $1,498,000.00 |
DisclosureSEC source: 0001209191-16-144880 · doc4.xml · nonDerivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2016 Filed Jul 26, 2016 21:20 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 325 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-16-000216 · edgardoc.xml · derivative · entry 2 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650 Underlying: Common Stock · 325 shares Expires 2019-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One-third of the RSU shares granted vested on Saturday, July 23, 2016. Accordingly the shares were released into Dr. Friedman's account on the first business day following vest, July 25, 2016. Read SEC document |
| July 25, 2016 Filed Jul 26, 2016 21:20 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 325 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-16-000216 · edgardoc.xml · nonDerivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2016 Filed Feb 1, 2017 14:27 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option · Derivative | 78,400 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001209191-17-006536 · doc5.xml · derivative · entry 2 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,400 Underlying: Common Stock · 78,400 shares Expires 2026-05-19 F2 · derivative.exercise_date: Annual equity award vesting in 36 equal monthly installments commencing one month from date of grant, being fully vested on the third anniversary of grant date. Read SEC document |
| May 19, 2016 Filed Feb 1, 2017 14:27 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantCommon Stock, $.01 Par Value | 39,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006536 · doc5.xml · nonDerivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,700 F1 · shares: Restricted Stock Units with 3-year vesting period; 1/36th vesting every month, being fully vested on the third anniversary of the grant date. Read SEC document |
| April 21, 2016 Filed Apr 22, 2016 13:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 327 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-16-000176 · edgardoc.xml · derivative · entry 2 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327 Underlying: Common Stock · 327 shares Expires 2020-04-21 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.